Failure of Pentavalent Antimony in Visceral Leishmaniasis in India: Report From the Center of the Indian Epidemic

Clin Infect Dis. 2000 Oct;31(4):1104-7. doi: 10.1086/318121.

Abstract

In India, 320 patients with visceral leishmaniasis (209 in the state of Bihar and 11 in the neighboring state of Uttar Pradesh) received identical pentavalent antimony (Sb) treatment. Sb induced long-term cure in 35% (95% confidence interval [CI], 28%-42%) of those in Bihar versus 86% (95% CI, 79%-93%) of those in Uttar Pradesh. In Bihar, the center of the Indian epidemic, traditional Sb treatment should be abandoned.

Publication types

  • Clinical Trial
  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Antimony Sodium Gluconate / therapeutic use*
  • Antiprotozoal Agents / therapeutic use*
  • Child
  • Child, Preschool
  • Disease Outbreaks*
  • Female
  • Humans
  • India / epidemiology
  • Infant
  • Leishmaniasis, Visceral / drug therapy*
  • Leishmaniasis, Visceral / epidemiology*
  • Male
  • Middle Aged
  • Treatment Failure

Substances

  • Antiprotozoal Agents
  • Antimony Sodium Gluconate